{
    "organizations": [],
    "uuid": "011b1afee917f82598c1bdc0f6dc4dc942fb0add",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biophytis-presents-positive-macune/brief-biophytis-presents-positive-macuneos-preclinical-study-results-clinical-studies-to-follow-idUSFWN1S41TK",
    "ord_in_thread": 0,
    "title": "BRIEF-Biophytis Presents Positive Macuneos Preclinical Study Results, Clinical Studies To Follow",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - BIOPHYTIS SA:\n* MACUNEOS WAS SHOWN TO SIGNIFICANTLY SLOW LOSS OF VISUAL FUNCTION IN PRECLINICAL MODEL OF DRY AMD\n* MACA-PK CLINICAL STUDY IS EXPECTED TO START IN SECOND HALF OF 2018\n* RESULTS CONFIRMING POTENTIAL OF MACUNEOS DRUG CANDIDATE IN TREATMENT OF INTERMEDIATE DRY FORM OF AMD\n* TO OBTAIN FIRST CLINICAL DATA OF MACA-PK PHASE 1/2A STUDY IN PATIENTS WITH AMD IN H1 2019\n* SAD PHASE WILL BE CONDUCTED IN SECOND HALF OF 2018 * MACA-INTEREST PHASE 2B CLINICAL TRIAL AUTHORIZATION APPLICATIONS ARE EXPECTED TO BE FILED IN FRANCE AND UNITED STATES IN SECOND HALF OF 2019\n* RESULTS OF THE MACA-INTEREST CLINICAL STUDY ARE EXPECTED AT THE END OF 2022\n* SECOND MAD PHASE SECOND MAD PHASE (MULTIPLE ASCENDING DOSES) WILL BE CONDUCTED IN 2019\n* RECRUITMENT FOR MACA-INTEREST STUDY SHOULD START AT THE END OF THE FIRST HALF OF 2020\n* MACA-OBS MULTICENTRIC OBSERVATIONAL CLINICAL STUDY IS EXPECTED TO START IN THE SECOND HALF OF 2018\n* MACUNEOS IS THE ONLY DRUG CANDIDATE IN CLINICAL DEVELOPMENT TO TREAT DRY AMD Source text: bit.ly/2FmwEo0 Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-28T00:18:00.000+03:00",
    "crawled": "2018-04-28T12:49:11.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "biophytis",
        "sa",
        "macuneos",
        "shown",
        "significantly",
        "slow",
        "loss",
        "visual",
        "function",
        "preclinical",
        "model",
        "dry",
        "amd",
        "clinical",
        "study",
        "expected",
        "start",
        "second",
        "half",
        "result",
        "confirming",
        "potential",
        "macuneos",
        "drug",
        "candidate",
        "treatment",
        "intermediate",
        "dry",
        "form",
        "amd",
        "obtain",
        "first",
        "clinical",
        "data",
        "phase",
        "study",
        "patient",
        "amd",
        "h1",
        "sad",
        "phase",
        "conducted",
        "second",
        "half",
        "phase",
        "2b",
        "clinical",
        "trial",
        "authorization",
        "application",
        "expected",
        "filed",
        "france",
        "united",
        "state",
        "second",
        "half",
        "result",
        "clinical",
        "study",
        "expected",
        "end",
        "second",
        "mad",
        "phase",
        "second",
        "mad",
        "phase",
        "multiple",
        "ascending",
        "dos",
        "conducted",
        "recruitment",
        "study",
        "start",
        "end",
        "first",
        "half",
        "multicentric",
        "observational",
        "clinical",
        "study",
        "expected",
        "start",
        "second",
        "half",
        "macuneos",
        "drug",
        "candidate",
        "clinical",
        "development",
        "treat",
        "dry",
        "amd",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}